HCMV infection downregulates nidogen 1 and myelin protein zero

NIH RePORTER · NIH · R01 · $375,000 · view on reporter.nih.gov ↗

Abstract

ABSTRACT Human Cytomegalovirus (HCMV) is a leading cause of congenital birth defects. The most common sequela observed in symptomatic infants is sensorineural hearing loss (SNHL). SNHL is also observed, somewhat perplexingly, during early childhood, developing over a period of years in children born hearing competent and asymptomatic for infection at birth. The most abundant peripheral nervous system (PNS) myelin protein, myelin protein zero (MPZ), is largely responsible for compaction of the PNS myelin sheath. Charcot-Marie-Tooth Type 1B and Dejerine-Sottas syndromes patients, with mutations in MPZ, frequently suffer from late-onset SNHL, similar to that observed in HCMV congenitally-infected children. MPZ expression is dramatically decreased in congenital HCMV-infected tissue samples. Schwarm cells (SCs) are the only cells in the body that produce MPZ. HCMV infection of SCs, or sole expression of the HCMV tegument protein pp71 in culture, causes large decreases in MPZ mRNA levels. SCs express MPZ protein only when directly contacting the neurons they sheathe, making a tractable co-culture system essential to studying defects in myelination. Substantial literature describes rat SC/neuron co-culture; however, very little work has reported using only human cells, essential for the study of species-restricted Human CMV pathogenesis. We have developed an all-human threedimensional (3D) SC/neuron co-culture system, amenable to the study of HCMV interactions. Our preliminary experiments have produced robust neurite outgrowth, SC/neuron interactions, MPZ expression and myelination. Initial experiments with pp71-expressing SCs produced very different interactions between the cell types and no evidence of myelination. In this application, we propose three AIMS. AIM 1 will fully characterize the co-culture system, establishing the baseline parameters of outgrowth and myelination, additionally assessing the functionality of the system using nerve conduction velocity studies, over a 30-day timecourse using wildtype SCs. After defining the co-culture system's baseline parameters, AIM 2 will assess the ramifications of HCMV infection and pp71 expression on all parameters defined in AIM 1. AIM 3 will utilize the co-culture system to examine crosstalk between the extracellular matrix (ECM) and myelin production, MPZ in particular, since the literature suggests a critical link between the ECM and SCs' ability to properly myelinate neurons. We believe this 3D system will enable us to accurately assess the effects ofHCMV infection on the developing PNS. Moreover, we believe our new system has the potential to be utilized by the wider scientific community studying interactions between glia and neurons and associated defects in myelination with an eye on its utilization as an efficient platform for drug discovery and development.

Key facts

NIH application ID
10882644
Project number
2R01AI139503-05
Recipient
UNIVERSITY OF IDAHO
Principal Investigator
ELIZABETH A FORTUNATO
Activity code
R01
Funding institute
NIH
Fiscal year
2024
Award amount
$375,000
Award type
2
Project period
2018-08-08 → 2029-02-28